H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Immunology D-index 79 Citations 18,470 314 World Ranking 689 National Ranking 32
Medicine D-index 87 Citations 25,153 543 World Ranking 6951 National Ranking 325

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Gene

His main research concerns Immunology, Multiple sclerosis, Immune system, T cell and CD8. His study in Immunology concentrates on Experimental autoimmune encephalomyelitis, IL-2 receptor, Autoimmunity, Antigen and Immune tolerance. Heinz Wiendl has included themes like Internal medicine, Central nervous system and Pathology in his Multiple sclerosis study.

As a member of one scientific family, he mostly works in the field of Immune system, focusing on Antibody and, on occasion, Epilepsy. His T cell research is multidisciplinary, incorporating perspectives in Inflammation, Blood–brain barrier, Cytokine and Cell biology. The study incorporates disciplines such as Regulatory T cell and Cytotoxic T cell in addition to CD8.

His most cited work include:

  • Expression of the B7-Related Molecule B7-H1 by Glioma Cells: A Potential Mechanism of Immune Paralysis (335 citations)
  • Leitlinien für Diagnostik und Therapie in der Neurologie (308 citations)
  • A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape. (300 citations)

What are the main themes of his work throughout his whole career to date?

Heinz Wiendl mostly deals with Multiple sclerosis, Immunology, Internal medicine, Immune system and Natalizumab. His work deals with themes such as Clinical trial, Disease, Pathology, Intensive care medicine and Alemtuzumab, which intersect with Multiple sclerosis. Heinz Wiendl works mostly in the field of Immunology, limiting it down to topics relating to Cytotoxic T cell and, in certain cases, CD8.

His work on Cohort as part of general Internal medicine study is frequently connected to In patient, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. The concepts of his Immune system study are interwoven with issues in Neuroinflammation, Antibody, Antigen and Cell biology. His Natalizumab study combines topics from a wide range of disciplines, such as Observational study, Fingolimod, Glatiramer acetate, Progressive multifocal leukoencephalopathy and Pediatrics.

He most often published in these fields:

  • Multiple sclerosis (40.31%)
  • Immunology (38.76%)
  • Internal medicine (20.65%)

What were the highlights of his more recent work (between 2017-2021)?

  • Multiple sclerosis (40.31%)
  • Internal medicine (20.65%)
  • Immunology (38.76%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Multiple sclerosis, Internal medicine, Immunology, Immune system and Natalizumab. The Multiple sclerosis study combines topics in areas such as Observational study, Cerebrospinal fluid, Alemtuzumab, Disease and Cohort. He usually deals with Internal medicine and limits it to topics linked to Clinically isolated syndrome and Cohort study.

His Immunology research is multidisciplinary, incorporating elements of Cell and Cytotoxic T cell. Heinz Wiendl has researched Immune system in several fields, including Inflammation, Neuroinflammation, Antigen and Cell biology. His studies in Natalizumab integrate themes in fields like Discontinuation, Fingolimod, Progressive multifocal leukoencephalopathy and Pediatrics.

Between 2017 and 2021, his most popular works were:

  • ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis: (199 citations)
  • ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis. (67 citations)
  • Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk (57 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Gene

Heinz Wiendl mainly focuses on Multiple sclerosis, Immunology, Immune system, Internal medicine and Natalizumab. His Multiple sclerosis research incorporates elements of Observational study, Alemtuzumab, Prospective cohort study and Intensive care medicine. His Immunology research integrates issues from Cytotoxic T cell and Cerebrospinal fluid.

His work deals with themes such as Cell, Neuroinflammation and Cell biology, which intersect with Immune system. His Internal medicine study incorporates themes from Expanded Disability Status Scale and Clinically isolated syndrome. His CD8 research includes elements of Inflammation and Central nervous system.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Expression of the B7-Related Molecule B7-H1 by Glioma Cells: A Potential Mechanism of Immune Paralysis

Sabine Wintterle;Bettina Schreiner;Meike Mitsdoerffer;Dagmar Schneider.
Cancer Research (2003)

511 Citations

Leitlinien für Diagnostik und Therapie in der Neurologie

H. C. Diener;C. Weimar;P. Berlit;G. Deuschl.
(2012)

475 Citations

A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape.

Heinz Wiendl;Meike Mitsdoerffer;Valeska Hofmeister;Jörg Wischhusen.
Journal of Immunology (2002)

461 Citations

Multiple sclerosis: comparison of copolymer-1- reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells.

Oliver Neuhaus;Cinthia Farina;Alexander Yassouridis;Heinz Wiendl.
Proceedings of the National Academy of Sciences of the United States of America (2000)

435 Citations

Acute disseminated encephalomyelitis: an update.

Til Menge;Bernhard Hemmer;Stefan Nessler;Heinz Wiendl.
JAMA Neurology (2005)

413 Citations

Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro.

Christian Blank;Juergen Kuball;Simon Voelkl;Heinz Wiendl.
International Journal of Cancer (2006)

384 Citations

Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis.

Christian G. Bien;Jan Bauer;Thomas L. Deckwerth;Heinz Wiendl.
Annals of Neurology (2002)

355 Citations

Interferon-β enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis

Bettina Schreiner;Meike Mitsdoerffer;Bernd C. Kieseier;Lieping Chen.
Journal of Neuroimmunology (2004)

327 Citations

Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation

Christoph Kleinschnitz;Nicholas Schwab;Peter Kraft;Ina Hagedorn.
Blood (2010)

310 Citations

Therapeutic approaches in multiple sclerosis: lessons from failed and interrupted treatment trials.

Heinz Wiendl;Reinhard Hohlfeld.
BioDrugs (2002)

301 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Heinz Wiendl

Hans-Peter Hartung

Hans-Peter Hartung

Heinrich Heine University Düsseldorf

Publications: 105

Ralf Gold

Ralf Gold

Ruhr University Bochum

Publications: 87

Olaf Stüve

Olaf Stüve

The University of Texas Southwestern Medical Center

Publications: 68

Bernd C. Kieseier

Bernd C. Kieseier

Heinrich Heine University Düsseldorf

Publications: 68

Hans Lassmann

Hans Lassmann

Medical University of Vienna

Publications: 64

Xavier Montalban

Xavier Montalban

Autonomous University of Barcelona

Publications: 62

Frauke Zipp

Frauke Zipp

Johannes Gutenberg University of Mainz

Publications: 61

Friedemann Paul

Friedemann Paul

Max Delbrück Center for Molecular Medicine

Publications: 59

Amit Bar-Or

Amit Bar-Or

University of Pennsylvania

Publications: 58

Gavin Giovannoni

Gavin Giovannoni

Queen Mary University of London

Publications: 56

Marinos C. Dalakas

Marinos C. Dalakas

Thomas Jefferson University

Publications: 55

Ludwig Kappos

Ludwig Kappos

University Hospital of Basel

Publications: 53

Giancarlo Comi

Giancarlo Comi

Vita-Salute San Raffaele University

Publications: 49

Robert Zivadinov

Robert Zivadinov

University at Buffalo, State University of New York

Publications: 48

Nathalie Rouas-Freiss

Nathalie Rouas-Freiss

French Alternative Energies and Atomic Energy Commission

Publications: 45

Helmut Butzkueven

Helmut Butzkueven

Monash University

Publications: 45

Something went wrong. Please try again later.